奥精医疗(688613.SH)：BioVeda已减持1.2996%的股份

格隆汇8月11日丨奥精医疗(688613.SH)公布，公司于2022年8月11日收到持股 5%以上股东BioVeda China RMB Investment Limited发来的告知函，BioVeda China RMB Investment Limited于2022年7月1日至2022年8月11日期间通过大宗交易和集中竞价方式减持公司股份共计173.2771万股，占公司总股本的1.2996%。

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.